A new study has identified sonographic biomarkers that can predict eventual malignant transformation of pathologically confirmed cirrhotic nodules for patients at risk for hepatocellular carcinoma (HCC). These additional imaging features may have the potential to be adopted as ancillary or even major features to stratify probability for HCC in the contrast-enhanced LI-RADS system.